Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. - Wikidata - awgldk - TriplyDB

Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men.

Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men.

http://www.wikidata.org/entity/Q34222234

about

Female pattern alopecia: current perspectives Dermatosis associated with menopause Androgenetic alopecia: an evidence-based treatment update Comparing the Effects of Zinc Sulfate, Calcium Pantothenate, Their Combination and Minoxidil Solution Regimens on Controlling Hair Loss in Women: A Randomized Controlled Trial.Use of low-level laser therapy as monotherapy or concomitant therapy for male and female androgenetic alopecia.New investigational drugs for androgenetic alopecia.Evidence-based treatments for female pattern hair loss: a summary of a Cochrane systematic review.Multi-therapies in androgenetic alopecia: review and clinical experiences.Study of platelet-rich plasma injections in the treatment of androgenetic alopecia through an one-year period.Low-level laser therapy as a treatment for androgenetic alopecia.The Diagnosis and Treatment of Hair and Scalp Diseases.Female Pattern Hair Loss: A Retrospective Study in a Tertiary Referral Center.Skin Manifestations of Insulin Resistance: From a Biochemical Stance to a Clinical Diagnosis and Management.Treatment options for alopecia: an update, looking to the future.A Spilt Head Study of Efficacy of Placebo versus Platelet-rich Plasma Injections in the Treatment of Androgenic Alopecia.The impact of oxidative stress on hair.Experimental and early investigational drugs for androgenetic alopecia.Androgenetic Alopecia: An Update of Treatment Options.Appraisal of guidelines for androgenetic alopecia using the Appraisal of Guidelines for Research and Evaluation II instrument.Androgenetic alopecia: a review.Topically used herbal products for the treatment of hair loss: preclinical and clinical studies.Understanding patient and physician perceptions of male androgenetic alopecia treatments in Asia-Pacific and Latin America.Conventional and novel stem cell based therapies for androgenic alopecia.Prevalence and associated factors of skin diseases in aged nursing home residents: a multicentre prevalence study Prioritizing dermatoses: rationally selecting guideline topics.An Asian traditional herbal complex containing Houttuynia cordata Thunb, Perilla frutescens Var. acuta and green tea stimulates hair growth in mice.Quality of life and psychosocial impact of scarring and non-scarring alopecia in women.Towards a consensus on how to diagnose and quantify female pattern hair loss - The 'Female Pattern Hair Loss Severity Index (FPHL-SI)'.Treatment of male androgenetic alopecia with topical products containing Serenoa repens extract.Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.An Open-Label Randomized Multicenter Study Assessing the Noninferiority of a Caffeine-Based Topical Liquid 0.2% versus Minoxidil 5% Solution in Male Androgenetic Alopecia.Effect of a nutritional supplement on hair loss in women.Enhanced skin permeation of 5α-reductase inhibitors entrapped into surface-modified liquid crystalline nanoparticles.Guidelines for management of androgenetic alopecia based on BASP classification--the Asian Consensus Committee guideline.Effect of sinapic acid on hair growth promoting in human hair follicle dermal papilla cells via Akt activation.[Androgenetic alopecia. Diagnosis and therapy- a current review].Possible association between androgenic alopecia and risk of prostate cancer and testicular germ cell tumor: a systematic review and meta-analysis.Drug Treatment for Androgenetic Alopecia: First Italian Questionnaire Survey on What Dermatologists Think about Finasteride.Female pattern hair loss

P2860

Q24626432-26201470-E47F-4D23-B82F-C4D314434085 Q27007070-CBACEF1B-FCA0-4338-BF53-B64FC6F2F06E Q28240536-2E3892B5-1DD4-4A8A-A3C9-ED9E727F7FB1 Q33777144-A39A4355-7778-491B-97B7-ECC59FEC1F08 Q34131281-F3F5B386-5E59-446D-9161-435186116FE9 Q34336651-6A59B21C-E461-4D50-A4F3-5D0ADED384D5 Q34434943-5489985B-4BCB-48D8-9757-DAFD57AAE17A Q34534360-CC65CAA5-702C-46EA-930F-F87036E7B5F4 Q35114015-93B28015-4896-4F5B-8716-A664D484272E Q35999049-2937E4AF-4E54-474A-AD7E-712480A0D11F Q37007243-4CC0A9AA-12BB-4857-8707-217E12EA9CD7 Q37185335-1AFBC8E9-6582-44E2-828F-2D7D69AD08A4 Q37679941-4FF5B4DC-9856-4230-8946-8E745CD48FBB Q38010773-33FD21F9-7757-4BF5-A9EF-AD7CB2DBEB45 Q38602914-0A236D80-FBB5-46CF-9942-33F6AF932955 Q38635021-E3B18635-1785-469E-BDAB-069B3BCAACD8 Q38660822-E788E5FC-5A93-4C07-88D1-33B8F6E461BE Q38935324-66D0ED89-4003-43B5-B1C4-8D1BD3FF7044 Q38949282-298B4A62-E230-4CFA-9178-080B3690C3F8 Q39204235-093997CF-F2B4-48A6-8EE4-911F8960863A Q39427624-6932DB43-44E3-4EEF-82AA-BAC4AA72F082 Q41540287-59F4A823-96CE-4920-B5F8-81F8E5B0DF59 Q42355136-2F2D2949-0AAF-4D9F-9D9B-27B194C5F0EC Q42368636-B9F08E18-37CA-4366-BF67-93E2C2980D6C Q42464851-617C9BE3-CADC-438B-9DA1-6E94F19FFDE1 Q47097554-F1678DDB-14E5-4B2D-B609-A4C475540AA4 Q47573552-40DE18AF-3E78-45F1-80B6-A95241DD5F46 Q47938688-48F8AAAA-6141-447A-9C67-BB9DE2E2A2E9 Q48183066-34CC8B3D-415C-4772-8367-E7F7EF2E410B Q48303063-CC53C4BB-FA5E-41E0-9662-A40D007433EA Q50064525-A7E20599-4E7A-493B-99F3-2D5EF9A8A2A2 Q51064636-FCF27943-FAB3-4762-BC1C-4FF189046278 Q51064970-4E1298B1-73B9-4B3D-A129-DE054EB61475 Q51297535-DA11D137-7172-4235-8F7D-EC9E94158B3B Q52780863-37B6DA47-9F1A-4B18-9317-E8AE5E609F3F Q52881974-7A1EDAAD-1DEA-4AE3-8D1B-066BBF72F0C8 Q55154528-30D786A2-704A-4230-8693-67A47BBE9EEA Q55354556-8A3E882B-BC57-4876-918A-2B918AB9148C Q55983044-E20F091E-018A-4CA5-B80A-90577FB6F8D9

P2860

Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men.

http://www.wikidata.org/entity/Q34222234

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Evidence-based (S3) guideline ...... alopecia in women and in men.

@ast

Evidence-based (S3) guideline ...... alopecia in women and in men.

@en

type

label

Evidence-based (S3) guideline ...... alopecia in women and in men.

@ast

Evidence-based (S3) guideline ...... alopecia in women and in men.

@en

prefLabel

Evidence-based (S3) guideline ...... alopecia in women and in men.

@ast

Evidence-based (S3) guideline ...... alopecia in women and in men.

@en

P1433

Q34222234-7F524656-5340-4785-BFD3-88521593C022

P1476

Q34222234-5F8632EC-42B7-4041-8DD1-B39C1302B85F

P2093

Q34222234-146A2A16-A742-4F84-861E-C5E75B9A3460

Q34222234-20B1E6F0-16DB-474F-AD7A-AF4963D995F8

Q34222234-324F83B5-7FA1-413E-BB3B-CEDA265FDAA4

Q34222234-3F772695-0D7E-4E8C-A085-A8CA5E0AEC2B

Q34222234-41679902-653E-4FE6-8E5B-14A29312B80A

Q34222234-62698F11-69FA-4113-A47D-309BF364F788

Q34222234-715CAC06-A244-44B9-B11E-26277B39A0A1

Q34222234-7A82E4EB-4BC8-4FE2-842C-F899C3CBD2FF

Q34222234-8D0351F0-A3EB-4797-9D71-3FE3A0B0DD0E

Q34222234-98BA5374-B33D-4976-AE7C-A73D25DE7648

P2860

Q34222234-178E7A31-BF5D-4C59-B126-A0DC1B3C5590

Q34222234-1B85E25E-335B-4779-9FB2-ECF9BEB93F47

Q34222234-1D054F14-17EE-4F05-83D3-41DFD75E664A

Q34222234-28D03B90-B4D2-4E12-BFB1-1F177F157E76

Q34222234-2FEF7B7A-3AF4-47BD-BB94-D6A0BE5C430C

Q34222234-30E9AA5B-2BDB-4FD0-9D21-80CE2E4B3773

Q34222234-38130102-9C34-4F84-8F66-C5CC18ED52E2

Q34222234-3E1CCD9E-A0F7-4F71-807F-C97C0117E273

Q34222234-433CB352-D134-436C-BDA2-DD56506FF45B

Q34222234-48ED0E0A-1BB3-41A1-9977-DF546FA5FC91

P304

Q34222234-1D759D5B-1D81-4B15-A46B-E6F2DF7B6E70

P31

Q34222234-3536FC0A-8854-4BD4-A715-D69E26DD5C54

P356

Q34222234-A44BC016-5E0A-4C13-A14A-285E9486E494

P478

Q34222234-C77E3A01-4205-43EB-B6CD-BBB466DD394E

P50

Q34222234-13DF7D73-95F9-4D1A-9A6F-6CB6C6B37707

P577

Q34222234-31D5C351-5195-42E4-A311-22D3435C25FF

P5875

Q34222234-78C2905E-1E43-4583-9B20-3BF5573CB003

P698

Q34222234-7C7D4F0D-4BFF-4587-90FB-84DEA5AC9E64

P356

J.1610-0379.2011.07802.X

P1433

P1476

Evidence-based (S3) guideline ...... alopecia in women and in men.

@en

P2093

Andreas Finner

http://www.w3.org/2001/XMLSchema#string

Andrew Messenger

http://www.w3.org/2001/XMLSchema#string

Anja Blumeyer

http://www.w3.org/2001/XMLSchema#string

Antonella Tosti

http://www.w3.org/2001/XMLSchema#string

Berthold Rzany

http://www.w3.org/2001/XMLSchema#string

European Dermatology Forum (EDF)

http://www.w3.org/2001/XMLSchema#string

Franklin Kiesewetter

http://www.w3.org/2001/XMLSchema#string

Myrto Trakatelli

http://www.w3.org/2001/XMLSchema#string

Pascal Reygagne

http://www.w3.org/2001/XMLSchema#string

Phyllis I Spuls

http://www.w3.org/2001/XMLSchema#string

P2860

Dissecting microscope versus magnifying loupes with transillumination in the preparation of follicular unit grafts. A bilateral controlled study.

Finasteride in the treatment of men with frontal male pattern hair loss.

Comparative efficacy of various treatment regimens for androgenetic alopecia in men.

Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group.

A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia.

Fluridil, a rationally designed topical agent for androgenetic alopecia: first clinical experience.

Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism.

Electrotrichogenesis: further evidence of efficacy and safety on extended use.

The biological effects of a pulsed electrostatic field with specific reference to hair. Electrotrichogenesis.

Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies: results of finasteride 1 mg treatment of men and postmenopausal women.

P304

S1-57

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1610-0379.2011.07802.X

http://www.w3.org/2001/XMLSchema#string

P478

9 Suppl 6

http://www.w3.org/2001/XMLSchema#string

P50

Ulrike Blume-Peytavi

P577

2011-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221699222

http://www.w3.org/2001/XMLSchema#string

P698

21980982

http://www.w3.org/2001/XMLSchema#string